Since circRNA CDR1as [18], miR-641 [26] and HOXA9 [27] involved in the regulation of drug resistance, we next investigated whether circRNA CDR1as/miR-641/HOXA9 pathway regulated cisplatin resistance in DDP-sensitive NSCLC cells. Here, HOXA9 is linked to non-small cell lung carcinoma.